Login to Your Account

Potential Milestones Exceed $1B

OncoMed Has 'Wnt' in its Sails; Bayer Deal Adds $40M Up Front

By Jennifer Boggs

Friday, June 18, 2010
For a firm that has yet to reach Phase II with a lead program, OncoMed Pharmaceuticals Inc. has managed some pretty impressive feats in the past few years. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription